Citadel Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25M Sell
4,700
-23,300
-83% -$6.31M ﹤0.01% 7163
2025
Q4
$7.02M Sell
28,000
-15,000
-35% -$3.98M ﹤0.01% 3754
2025
Q3
$12.3M Buy
43,000
+3,300
+8% +$884K ﹤0.01% 2950
2025
Q2
$10.4M Sell
39,700
-23,000
-37% -$5.6M ﹤0.01% 2963
2025
Q1
$14.6M Sell
62,700
-43,400
-41% -$10.5M ﹤0.01% 2386
2024
Q4
$24.3M Buy
106,100
+37,100
+54% +$8.51M ﹤0.01% 1957
2024
Q3
$15.4M Buy
69,000
+21,100
+44% +$4.64M ﹤0.01% 2345
2024
Q2
$9.75M Buy
47,900
+18,500
+63% +$3.76M ﹤0.01% 2808
2024
Q1
$6.42M Sell
29,400
-11,100
-27% -$2.45M ﹤0.01% 3574
2023
Q4
$9.21M Sell
40,500
-85,400
-68% -$17.9M ﹤0.01% 2961
2023
Q3
$25.3M Buy
125,900
+45,351
+56% +$9.57M 0.01% 1635
2023
Q2
$16.7M Sell
80,549
-66,348
-45% -$12.9M ﹤0.01% 2070
2023
Q1
$29M Sell
146,897
-46,793
-24% -$9.63M 0.01% 1564
2022
Q4
$39.2M Buy
193,690
+150,389
+347% +$29.4M 0.01% 1314
2022
Q3
$7.62M Sell
43,301
-14,201
-25% -$2.91M ﹤0.01% 3167
2022
Q2
$11.6M Sell
57,502
-4,423
-7% -$943K ﹤0.01% 2491
2022
Q1
$14M Sell
61,925
-9,777
-14% -$2.3M ﹤0.01% 2456
2021
Q4
$19.4M Buy
71,702
+25,026
+54% +$6.2M ﹤0.01% 2059
2021
Q3
$11.3M Sell
46,676
-932
-2% -$235K ﹤0.01% 2863
2021
Q2
$11.3M Sell
47,608
-4,074
-8% -$928K ﹤0.01% 2895
2021
Q1
$11.3M Sell
51,682
-24,211
-32% -$4.86M ﹤0.01% 2794
2020
Q4
$13.3M Buy
75,893
+10,243
+16% +$1.77M ﹤0.01% 2273
2020
Q3
$10.6M Sell
65,650
-15,015
-19% -$2.38M ﹤0.01% 2221
2020
Q2
$11.5M Buy
80,665
+35,618
+79% +$4.93M ﹤0.01% 2064
2020
Q1
$4.89M Buy
45,047
+26,889
+148% +$3.87M ﹤0.01% 2735
2019
Q4
$2.64M Sell
18,158
-4,773
-21% -$689K ﹤0.01% 3985
2019
Q3
$3.31M Sell
22,931
-10,592
-32% -$1.55M ﹤0.01% 3698
2019
Q2
$4.98M Buy
33,523
+1,746
+5% +$244K ﹤0.01% 3087
2019
Q1
$4.18M Buy
31,777
+6,518
+26% +$803K ﹤0.01% 3253
2018
Q4
$2.74M Sell
25,259
-18,507
-42% -$2.48M ﹤0.01% 3671
2018
Q3
$6.53M Buy
43,766
+12,687
+41% +$1.93M ﹤0.01% 2638
2018
Q2
$4.79M Sell
31,079
-4,190
-12% -$632K ﹤0.01% 2836
2018
Q1
$4.9M Buy
35,269
+3,725
+12% +$547K ﹤0.01% 2481
2017
Q4
$4.32M Buy
31,544
+26,306
+502% +$3.48M ﹤0.01% 2650
2017
Q3
$679K Buy
5,238
+1,630
+45% +$217K ﹤0.01% 4883
2017
Q2
$478K Sell
3,608
-14,434
-80% -$1.77M ﹤0.01% 5178
2017
Q1
$2.22M Sell
18,042
-50,750
-74% -$6.01M ﹤0.01% 2959
2016
Q4
$7.59M Sell
68,792
-5,006
-7% -$556K 0.01% 1600
2016
Q3
$8.72M Buy
73,798
+59,132
+403% +$6.97M 0.01% 1491
2016
Q2
$1.64M Sell
14,666
-13,736
-48% -$1.48M ﹤0.01% 2949
2016
Q1
$2.86M Sell
28,402
-7,449
-21% -$714K ﹤0.01% 2295
2015
Q4
$3.81M Buy
35,851
+17,809
+99% +$1.84M ﹤0.01% 2069
2015
Q3
$1.68M Buy
18,042
+11,291
+167% +$1.17M ﹤0.01% 3160
2015
Q2
$703K Sell
6,751
-12,106
-64% -$1.26M ﹤0.01% 4463
2015
Q1
$2.04M Buy
18,857
+1,979
+12% +$204K ﹤0.01% 3032
2014
Q4
$1.56M Buy
16,878
+1,397
+9% +$123K ﹤0.01% 3202
2014
Q3
$1.35M Sell
15,481
-6,402
-29% -$578K ﹤0.01% 3326
2014
Q2
$1.93M Buy
21,883
+6,635
+44% +$575K ﹤0.01% 2759
2014
Q1
$1.29M Sell
15,248
-3,143
-17% -$251K ﹤0.01% 3114
2013
Q4
$1.44M Buy
18,391
+11,640
+172% +$993K ﹤0.01% 2852
2013
Q3
$575K Buy
6,751
+815
+14% +$68.6K ﹤0.01% 3650
2013
Q2
$511K Buy
+5,936
New +$493K ﹤0.01% 3828

Other funds holding LH

Citadel Advisors's LH Position: Q1 2026 in Review

Citadel Advisors reduced its Labcorp (LH) stake by 52% in Q1 2026, selling an estimated $20.8M and leaving 71,339 shares worth $19M. The position accounts for ﹤0.01% of the portfolio, ranked #2393.

Citadel Advisors first reported a position in LH in Q2 2013 and has held it in 50 quarters since. The position peaked at $328M in Q4 2024. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Citadel Advisors held 71,339 shares of Labcorp worth $19M as of Q1 2026.
  • Citadel Advisors sold 76,957 Labcorp shares in Q1 2026, an estimated $20.8M.
  • Labcorp made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2393 holding.
  • Citadel Advisors first reported a position in Labcorp in Q2 2013 and has held it in 50 quarters since.
  • Citadel Advisors's Labcorp position peaked at $328M in Q4 2024.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.